Policy paper

Clinical trials transparency: government response to the Science and Technology Committee's inquiry

Command paper responding to the House of Commons Science and Technology Committee inquiry report 'Research Integrity: Clinical Trials Transparency'.

• From: Department of Health and Social Care
• Published: 22 February 2019

This was published under the 2016 to 2019 May Conservative government

Documents

Government response to the House of Commons Science and Technology Committee report on research integrity: clinical trials transparency

HTML

Government response to the House of Commons Science and Technology Committee report on research integrity: clinical trials transparency

Ref: CCS0219582564, CP 24

PDF, 198 KB, 10 pages

Order a copy

Government response to the House of Commons Science and Technology Committee report on research integrity: clinical trials transparency (print version)

Ref: ISBN 978-1-5286-1065-0

PDF, 747 KB, 16 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

This command paper sets out the government’s response to the Science and Technology Committee’s inquiry report on clinical trials transparency published by the House of Commons in October 2018.

Published 22 February 2019